We are live on ! Find out more
IH

iHuman
IH

6 hedge funds and large institutions have $7.46M invested in iHuman in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.25% less ownership

Funds ownership: 6.91% → 6.66% (-0.25%)

25% less funds holding

Funds holding: 8 → 6 (-2)

28% less capital invested

Capital invested by funds: $10.3M → $7.46M (-$2.86M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$5.98K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$150K
2
Goldman Sachs
Goldman Sachs
New York
-$129K
3
UBS Group
UBS Group
Switzerland
-$11K
4
Millennium Management
Millennium Management
New York
-$7.82K
5
Bank of America
Bank of America
North Carolina
-$6.46K

IH Hedge Fund Activity: Q1 2022 in Review

6 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q1 2022, worth a combined $7.46M — down 28% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of IH and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was State Street, adding an estimated $5.98K. The largest seller was Morgan Stanley, cutting an estimated $150K.

  • 6 institutional investors held iHuman (IH) as of Q1 2022, down from 8 in Q4 2021.
  • Funds reported $7.46M of iHuman stock for Q1 2022, down 28% quarter-over-quarter.
  • 0 funds opened new iHuman positions in Q1 2022 and 2 closed out, a net change of -2 holders.
  • The largest iHuman buyer in Q1 2022 was State Street, an estimated $5.98K added.
  • The largest iHuman seller in Q1 2022 was Morgan Stanley, an estimated $150K sold.

Based on aggregated 13F filings for Q1 2022.